Log in
Enquire now
AlphaCognition

AlphaCognition

Alpha Cognition is a clinical stage, biopharmaceutical company developing treatments for neurodegenerative diseases such as Alzheimer’s Dementia and Amyotrophic Lateral Sclerosis (ALS).

OverviewStructured DataIssuesContributors

Contents

alphacognition.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
‌
Neurodegenerative Disease
Biomedical engineering
Biomedical engineering
Healthcare
Healthcare
Medicine
Medicine
‌
Neurobiology
Engineering
Engineering
Biopharmaceutical
Biopharmaceutical
Alzheimer's disease
Alzheimer's disease
Location
Vancouver
Vancouver
Legal Name
Alpha Cognition Inc.0
Legal classification
Corporation
Corporation
Date Incorporated
2014
Email Address
info@alphacognition.com
CIK Number
1,655,923
Place of Incorporation
British Columbia
British Columbia
Founded Date
2014
Total Funding Amount (USD)
12,251,093
Latest Funding Round Date
April 2020
Country
Canada
Canada

Other attributes

Latest Funding Round Amount (USD)
1,915,000
Previous Name
Neurodyn Cognition Inc.0
No article content yet.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like AlphaCognition

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Pricing
  • Enterprise

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.